Recruiting

The Effect of Walking Exercise in Patients With Chronic Obstructive Pulmonary Disease

"Patients were divided into two groups: the experimental group (E group) and the control group (C group). The E group received standard care, walking exercise, and elastic band exercise, and wore a smart bracelet to record walking steps and sleep for three months. During the first month, participants performed walking exercise for 100 minutes per week and used a red elastic band for resistance training. In the second month, walking exercise increased to 150 minutes per week with a green elastic band. In the third…

ClinicalTrials.gov IDNCT07185659
PhaseNA
Enrollment68
SponsorTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Age40 Years – 100 Years
SexALL
I'm interested View official listing

Conditions studied

Chronic Obstructive Pulmonary Disease (COPD)

About this study

"Patients were divided into two groups: the experimental group (E group) and the control group (C group). The E group received standard care, walking exercise, and elastic band exercise, and wore a smart bracelet to record walking steps and sleep for three months. During the first month, participants performed walking exercise for 100 minutes per week and used a red elastic band for resistance training. In the second month, walking exercise increased to 150 minutes per week with a green elastic band. In the third month, walking exercise increased to 150-300 minutes per week with a blue elastic band. The C group wore the smart bracelet to record walking steps and sleep for three months. Each group included 34 participants. The study was conducted from September 9, 2021, to December 31, 2025. Exclusion criteria included panic disorder, cognitive impairment, current cancer treatment, angina pectoris or myocardial infarction within the past 3 months, participation in high-intensity rehabilitation exercise, and walking dysfunction. Participants were required to follow the study protocol. * Assessments\*\*: * Anxiety and Depression\*\*:Measured using the Chinese version of the Hospital Anxiety and Depression Scale (HADS). * Dyspnea\*\*:Measured using the Modified Medical Research Council (mMRC) scale. * Life and Sleep quality\*\*:Measured using the COPD Assessment Test (CAT) and Chinese Version of the Pittsburgh Sleep Quality Index (CPSQI).

Interventions

Primary outcomes

Eligibility information

Participants were recruited according to the following criteria. Inclusion Criteria: * Inpatients diagnosed with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. * Age ≥ 40 years. * Post-bronchodilator FEV₁/FVC ratio \< 70%. * History of smoking. * Ability to perform walking exercises. * Willingness of the patient or a family member to provide written informed consent. Exclusion Criteria: * Panic disorder. * Presence of delirium with inability to cooperate. * Currently receiving cancer treatment. * Angina pectoris or myocardial infarction within the past 3 months. * Currently undergoing high-intensity rehabilitation exercises.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-07.